Skip to content
2000
Volume 24, Issue 46
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background: Besides the numerous biologic and pharmacologic functions in the human body that act as potent antioxidants, flavonoids (flavones, flavanones, flavonols, flavanols and isoflavones) are noted as cancer preventive or therapeutic agents. Methods: This review summarizes the published data using PubMed, Science Direct, and Scopus. Results: In this context, recognition and introduction of the most active cytotoxic flavonoids as promising agents for cancer therapy gives insight for further evaluations. However, there are some critical points that may affect the entering of flavonoids as active cytotoxic phytochemicals in the clinical phase. Issues such as the abundance of active species in nature, the methods of extraction and purification, solubility, pharmacokinetic profile, presence of the chiral moieties, method of synthesis, and structure modification may limit the entry of a selected compound for use in humans. Although plenty of basic evidence exists for cytotoxic/antitumor activity of the versatility of flavonoids for entry into clinical trials, the above-mentioned concerns must be considered. Conclusion: This review is an effort to introduce cytotoxic natural flavonoids (IC50< 10 μM) that may have the potential to be used against various tumor cells. Also, active constituents, molecular mechanisms, and related clinical trials have been discussed as well as the limitations and challenges of using flavonoids in clinic.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612825666190222142537
2018-12-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612825666190222142537
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test